News
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
U.S. District Judge Mark Walker says Upside Foods has plausibly alleged that the law's protectionism violates the "dormant" ...
CT Insider on MSN57m
Stamford-based drug developer for rare cancers and tumors sold for $3.9 billion to German companyA German-based company is buying SpringWorks Therapeutics for $3.9 billion years after the local company developed a drug to treat rare tumors and is expanding to tackle varying forms of cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback